Pregnancy outcomes of placenta accreta spectrum with and without previa

Document Type : Original Article

Authors

1 Associate Professor, Department of Midwifery, Reproductive Health Promotion Research Center, School of Nursing and Midwifery, Ahvaz Jundishapour University of Medical Sciences, Ahvaz, Iran.

2 Professor, Department of Obstetrics and Gynecology, Faculty of Medicine, Ahvaz Jundishapour University of Medical Sciences, Ahvaz, Iran.

3 Instructor, Department of Midwifery, Menopause Andropause Research Center, School of Nursing and Midwifery, Ahvaz Jundishapour University of Medical Sciences, Ahvaz, Iran.

4 Assistant Professor, Department of Epidemiology, Menopause Andropause Research Center, School of Health, Ahvaz Jundishapour University of Medical Sciences, Ahvaz, Iran.

Abstract

Introduction: Abnormal adhesion of placenta is one of the complex problems of gynecology and obstetrics and is considered life-threatening for mother and fetus. The present study was performed aimed to compare the pregnancy outcomes in placenta accreta with and without previa.
Methods: In this analytical-comparison study, the medical records of 50037 women who had referred to Imam Khomeini Hospital in Ahvaz for delivery in 2015-2019 were examined for the diagnosis and recording of abnormal placental adhesions. A total of 172 patients were confirmed with a definite diagnosis of abnormal placental adhesions that they were divided into two groups of accreta (n=95) and accreta with previa (n=7) for evaluation and comparison. Data were analyzed by SPSS (version 24) and Chi-square, T–test, and Man-Whitney test. P<0.05 was considered statistically significant.
Results: There was no significant difference between the two groups in terms of number of pregnancy (P=0.884), number of cesarean (P=0.771), history of abortion (P=0.384), and gestational diabetes (P=0.824). Antenatal bleeding in accreta–privia group was 2.43 times of accreta group (OR: 2.34, 95% CI: 1.22-45, p=0.009) and there was significant difference between the two groups. No significant difference was observed between the two groups in the frequency of hysterectomy, percentage of blood transfusion, admission to ICU and the units of used blood, but cystostomy in previa-accreta group was 2.2 times to accreta group (P=0.027). There was significant difference between the two groups in terms of gestational age at birth (p=0.004), birth weight (p=0.054), and percentage of preterm delivery (P=0.015); so that gestational age and birth weight were significantly lower in the accreta-previa group.
Conclusion: In both groups, accreta and accreta with previa were similar risk factors, but the needs for cystostomy and preterm delivery was significantly more in the accrete-previa group.

Keywords

References

  1. Gielchinsky Y, Rojansky N, Fasouliotis SJ, Ezra Y. Placenta accreta—summary of 10 years: a survey of 310 cases. Placenta 2002; 23(2-3):210-4.
  2. Wortman AC, Alexander JM. Placenta accreta, increta, and percreta. Obstetrics and Gynecology Clinics 2013; 40(1):137-54.
  3. Diag FP, Jauniaux E, Chantraine F, Silver RM, Langhoff-Roos J, Tikkanen M. FIGO consensus guidelines on placenta accreta spectrum disorders: epidemiology. International Journal of Gynecology & Obstetrics 2018; 140(3):265-73.
  4. Bartels HC, Postle JD, Downey P, Brennan DJ. Placenta accreta spectrum: a review of pathology, molecular biology, and biomarkers. Disease markers 2018; 2018.
  5. Betrán AP, Ye J, Moller AB, Zhang J, Gülmezoglu AM, Torloni MR. The increasing trend in caesarean section rates: global, regional and national estimates: 1990-2014. PloS one 2016; 11(2):e0148343.
  6. Thurn L, Lindqvist PG, Jakobsson M, Colmorn LB, Klungsoyr K, Bjarnadóttir RI, et al. Abnormally invasive placenta—prevalence, risk factors and antenatal suspicion: results from a large population‐based pregnancy cohort study in the Nordic countries. BJOG: An International Journal of Obstetrics & Gynaecology 2016; 123(8):1348-55.
  7. Eshkoli T, Weintraub AY, Sergienko R, Sheiner E. Placenta accreta: risk factors, perinatal outcomes, and consequences for subsequent births. American journal of obstetrics and gynecology 2013; 208(3):219-e1.
  8. Garmi G, Salim R. Epidemiology, etiology, diagnosis, and management of placenta accreta. Obstetrics and gynecology international 2012; 2012.
  9. Pourali L, Golmohammadi M, Ayati S, Moeen Darbari S. Hysterectomy due to placenta accreta in a primigravid woman with increased maternal age: a case report. Iran J Obstet Gynecol Infertil 2015; 18(140):15-9.
  10. Jauniaux E, Collins S, Burton GJ. Placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging. American journal of obstetrics and gynecology 2018; 218(1):75-87.
  11. American College of Obstetricians and Gynecologists, Society for Maternal-Fetal Medicine. Obstetric care consensus no. 7: placenta accreta spectrum. Obstetrics and gynecology 2018; 132(6):e259-75.
  12. Abuhamad A. Morbidly adherent placenta. Semin Perinatol 2013; 37(5):359-64.
  13. Publications Committee, Society for Maternal-Fetal Medicine, Belfort MA. Placenta accreta. Am J Obstet Gynecol 2010; 203(5):430-9.
  14. Tunçalp Ö, Hindin MJ, Souza JP, Chou D, Say L. The prevalence of maternal near miss: a systematic review. BJOG: An International Journal of Obstetrics & Gynaecology 2012; 119(6):653-61.
  15. Wu S, Kocherginsky M, Hibbard JU. Abnormal placentation: twenty-year analysis. American journal of obstetrics and gynecology 2005; 192(5):1458-61.
  16. Carusi DA. The placenta accreta spectrum: epidemiology and risk factors. Clinical obstetrics and gynecology 2018; 61(4):733-42.
  17. Fan D, Wu S, Liu L, Xia Q, Wang W, Guo X, et al. Prevalence of antepartum hemorrhage in women with placenta previa: a systematic review and meta-analysis. Scientific reports 2017; 7(1):1-9.
  18. Jauniaux E, Dimitrova I, Kenyon N, Mhallem M, Kametas NA, Zosmer N, et al. Impact of placenta previa with placenta accreta spectrum disorder on fetal growth. Ultrasound in Obstetrics & Gynecology 2019; 54(5):643-9.
  19. Bluth A, Schindelhauer A, Nitzsche K, Wimberger P, Birdir C. Placenta accreta spectrum disorders—experience of management in a German tertiary perinatal centre. Archives of Gynecology and Obstetrics 2021; 303(6):1451-60.
  20. Morlando M, Collins S. Placenta accreta spectrum disorders: challenges, risks, and management strategies. International Journal of Women's Health 2020; 12:1033.
  21. Mulla BM, Weatherford R, Redhunt AM, Modest AM, Hacker MR, Hecht JL, et al. Hemorrhagic morbidity in placenta accreta spectrum with and without placenta previa. Archives of gynecology and obstetrics 2019; 300(6):1601-6.
The Iranian Journal of Obstetrics, Gynecology and Infertility
Volume 25, Issue 8
October 2022
Pages 19-25

Files

Share

How to cite

Statistics